Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Comparative analysis of decision maker preferences for equity/efficiency attributes in reimbursement decisions in three European countries

P. Baji, M. García-Goñi, L. Gulácsi, E. Mentzakis, F. Paolucci,

. 2016 ; 17 (7) : 791-9. [pub] 20150822

Language English Country Germany

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc17024234

BACKGROUND: In addition to cost-effectiveness, national guidelines often include other factors in reimbursement decisions. However, weights attached to these are rarely quantified, thus decisions can depend strongly on decision-maker preferences. OBJECTIVE: To explore the preferences of policymakers and healthcare professionals involved in the decision-making process for different efficiency and equity attributes of interventions and to analyse cross-country differences. METHOD: Discrete choice experiments (DCEs) were carried out in Austria, Hungary, and Norway with policymakers and other professionals working in the health industry (N = 153 respondents). Interventions were described in terms of different efficiency and equity attributes (severity of disease, target age of the population and willingness to subsidise others, potential number of beneficiaries, individual health benefit, and cost-effectiveness). Parameter estimates from the DCE were used to calculate the probability of choosing a healthcare intervention with different characteristics, and to rank different equity and efficiency attributes according to their importance. RESULTS: In all three countries, cost-effectiveness, individual health benefit and severity of the disease were significant and equally important determinants of decisions. All countries show preferences for interventions targeting young and middle aged populations compared to those targeting populations over 60. However, decision-makers in Austria and Hungary show preferences more oriented to efficiency than equity, while those in Norway show equal preferences for equity and efficiency attributes. CONCLUSION: We find that factors other than cost-effectiveness seem to play an equally important role in decision-making. We also find evidence of cross-country differences in the weight of efficiency and equity attributes.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17024234
003      
CZ-PrNML
005      
20170906124855.0
007      
ta
008      
170720s2016 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s10198-015-0721-x $2 doi
035    __
$a (PubMed)26296623
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Baji, Petra $u Department of Health Economics, Corvinus University of Budapest, Fővám tér 8., Budapest, 1093, Hungary. petra.baji@uni-corvinus.hu. CERGE-EI, Prague, Czech Republic. petra.baji@uni-corvinus.hu.
245    10
$a Comparative analysis of decision maker preferences for equity/efficiency attributes in reimbursement decisions in three European countries / $c P. Baji, M. García-Goñi, L. Gulácsi, E. Mentzakis, F. Paolucci,
520    9_
$a BACKGROUND: In addition to cost-effectiveness, national guidelines often include other factors in reimbursement decisions. However, weights attached to these are rarely quantified, thus decisions can depend strongly on decision-maker preferences. OBJECTIVE: To explore the preferences of policymakers and healthcare professionals involved in the decision-making process for different efficiency and equity attributes of interventions and to analyse cross-country differences. METHOD: Discrete choice experiments (DCEs) were carried out in Austria, Hungary, and Norway with policymakers and other professionals working in the health industry (N = 153 respondents). Interventions were described in terms of different efficiency and equity attributes (severity of disease, target age of the population and willingness to subsidise others, potential number of beneficiaries, individual health benefit, and cost-effectiveness). Parameter estimates from the DCE were used to calculate the probability of choosing a healthcare intervention with different characteristics, and to rank different equity and efficiency attributes according to their importance. RESULTS: In all three countries, cost-effectiveness, individual health benefit and severity of the disease were significant and equally important determinants of decisions. All countries show preferences for interventions targeting young and middle aged populations compared to those targeting populations over 60. However, decision-makers in Austria and Hungary show preferences more oriented to efficiency than equity, while those in Norway show equal preferences for equity and efficiency attributes. CONCLUSION: We find that factors other than cost-effectiveness seem to play an equally important role in decision-making. We also find evidence of cross-country differences in the weight of efficiency and equity attributes.
650    _2
$a věkové faktory $7 D000367
650    _2
$a výběrové chování $7 D002755
650    _2
$a analýza nákladů a výnosů $7 D003362
650    12
$a rozhodování $7 D003657
650    12
$a efektivita organizační $7 D017598
650    _2
$a Evropa $7 D005060
650    _2
$a směrnice jako téma $7 D017408
650    _2
$a přidělování zdravotní péče $x ekonomika $x organizace a řízení $7 D015276
650    _2
$a lidé $7 D006801
650    _2
$a stupeň závažnosti nemoci $7 D012720
655    _2
$a časopisecké články $7 D016428
700    1_
$a García-Goñi, Manuel $u Departamento de Economía Aplicada II, Universidad Complutense de Madrid, Madrid, Spain.
700    1_
$a Gulácsi, László $u Department of Health Economics, Corvinus University of Budapest, Fővám tér 8., Budapest, 1093, Hungary.
700    1_
$a Mentzakis, Emmanouil $u Economics Department, School of Social Sciences, University of Southampton, Southampton, UK.
700    1_
$a Paolucci, Francesco $u University of Bologna, Bologna, Italy. Murdoch University, Murdoch, Australia.
773    0_
$w MED00007432 $t The European journal of health economics HEPAC health economics in prevention and care $x 1618-7601 $g Roč. 17, č. 7 (2016), s. 791-9
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26296623 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20170906125453 $b ABA008
999    __
$a ok $b bmc $g 1239915 $s 985147
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 17 $c 7 $d 791-9 $e 20150822 $i 1618-7601 $m The European journal of health economics $n Eur J Health Econ $x MED00007432
LZP    __
$a Pubmed-20170720

Find record

Citation metrics

Archiving options